PMGC Holdings ELAB
NASDAQ ELAB
$6.45 +0.35 (+5.74%)
As of: Aug 21, 2026 · 1:22 PM EDT

PMGC Holdings (ELAB) Capital Expenditures (2022 - 2026)

PMGC Holdings (ELAB) posted Capital Expenditures of $363087.0 for Q1 2026, up 4.74% sequentially from $346661.0 in Q4 2025.

PMGC Holdings (ELAB) Capital Expenditures (2022 - 2026) Analysis & Trends

PMGC Holdings has reported Capital Expenditures for 5 years, with the latest figure at $363087.0 in Q1 2026.

  • Quarterly Capital Expenditures changed N/A year-over-year to $363087.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $709748.0 (changed N/A YoY) and the FY2025 annual result came in at $442255.0, up 4728.11% from the prior year.
  • Capital Expenditures rose to $363087.0 in Q1 2026 per ELAB's latest filing, from $346661.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $363087.0 in Q1 2026 and troughed at -$36.9 million in Q4 2022.
  • A 5-year average of -$7.2 million and a median of $11191.0 in 2023 frame the typical range for Capital Expenditures.
  • The widest YoY moves for Capital Expenditures: up 18.15% in 2024, down 18.15% in 2024.
  • Over 5 years, Capital Expenditures stood at -$36.9 million in 2022, then soared by 100.03% to $11191.0 in 2023, then retreated by 18.15% to $9160.0 in 2024, then surged by 3684.51% to $346661.0 in 2025, then grew by 4.74% to $363087.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $363087.0, $346661.0, and $9160.0 for Q1 2026, Q4 2025, and Q1 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Vertex Pharmaceuticals 139.20 Bn 131.35 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 86.09 Bn 78.10 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 65.25 Bn 60.07 Bn 1.37 Bn -
4 Moderna 59.04 Bn 53.90 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 42.04 Bn 36.94 Bn 1.53 Bn 25.02 Mn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn 34.68 Mn
7 BioNTech SE 28.04 Bn 9.65 Bn 668.28 Mn -73.57 Mn
8 Insmed 27.50 Bn 26.33 Bn 358.27 Mn 6.26 Mn
9 Royalty Pharma 27.34 Bn 26.50 Bn - 251.02 Mn
10 PMGC Holdings 31.45 Mn 12.66 Mn 385,691.00 -27,569.00

Historic Data

Download Data
DateValue
Mar 31, 2026 363,087.00
Mar 31, 2026 363,087.00
Dec 31, 2025 346,661.00
Dec 31, 2025 346,661.00
Mar 31, 2024 9,160.00
Mar 31, 2024 9,160.00
Mar 31, 2023 11,191.00
Mar 31, 2023 11,191.00
Dec 31, 2022 -36.89 Mn
Dec 31, 2022 -36.89 Mn